Atlas Trials

Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer

Clinical trial NCT02945631 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02945631
Sponsor
Icahn School of Medicine at Mount Sinai
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Locally Advanced HPV Positive Oropharynx Cancer
Start date
2016-04-25
Primary completion
2027-12-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.